Breast Cancer Diagnostic Market: Infrastructure Growth and Development 2018 to 2026 Breast Cancer Diagnostic Market - Global industry insights, Outlook and Opportunity Analysis, 2018-2026 Breast cancer is characterized by a malignant tumor formed in the breast cells, which can spread to other parts of the body. Breast cancer is majorly observed in females. Breast cancer is diagnosed by doctors with the help of several tests to locate the site of initiation and the spread of the tumor to several parts of the body. Symptoms of breast cancer includes lump in a breast, change in the shape of breast, skin dimpling, and fluid leakage from the nipple, patches on the skin, etc. Breast cancer can be developed in normal individuals due to several risk factors that involves low physical exertion, alcohol consumption, obesity, menopause, family history and delivering a child at an older age. Breast cancer can be diagnosed at early stages by certain screening tests like yearly mammograms, CT scans, and MRI. Once the symptoms are visually detectable, an individual is advised to undergo diagnostic test to confirm the suspects of the breast cancer. Click To Read More On Breast Cancer Diagnostic Market. Alarming rise in incidence of breast cancer augmenting market growth According to the National Cancer Institute (NCI), 2015, in the U.S. around 232,340 females were encountered with breast cancer and out of which 39,620 cases were lethal. The data from NCI also suggests that 22.9% of female cancers in women accounts to breast cancer while, 18.2% of all the deaths caused due to cancer, contributes to breast cancer. The American Cancer Society (ACS) states that 1 out of 4 patients diagnosed with cancer are victims of breast cancer and is the most commonly observed cancer in females. Ask For Sample Copy Of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-sample/425 Increase in incidence of breast cancer worldwide is the prime reason for global breast cancer diagnostic market growth over the forecast period Regional segmentation of the breast cancer diagnostic market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. The major reason driving the breast cancer diagnostic market is the increasing incidence rate of breast cancer all over the globe. The WHO suggests that 89.7 per 100,000 people in Western Europe are affected by breast cancer per year. Apart from this, certain factors like increasing awareness among people regarding regular check- ups for early detection of breast cancer, technological advancement in medical imaging technologies, funding provided by government in research and development of breast cancer treatment and diagnostic techniques are responsible to fuel the global market of breast cancer diagnostics. Moreover, the rise in geriatric population offers high growth to the players of global market. Strikingly, the breast cancer survival rates worldwide are relatively high, making it an important factor that is responsible to drive the breast cancer diagnostic industry. WHO states that survival rates are around 80% in North America, Sweden and Japan. However, as the installation cost of breast cancer diagnostic devices and imaging facilities and side effects of radiation, may result in hindering the growth of the breast cancer diagnostic market. Modalities like CT scan and MRI imaging can provide non-invasive, quick and pain free solution for breast cancer diagnosis The global breast cancer diagnostic market is segmented on the basis of diagnostic type, end user and geography. On the basis of diagnostic type the global market is segmented as: 1.Ionizing breast imaging technologies: These can be sub- segmented as•Analog Mammography •Full field digital mammography (FFDM) •3D breast tomosynthesis •Positron emission tomography/ Computed tomography (PET/CT) •Molecular Breast imaging/ breast specific gamma imaging (MBI/BSMI) •Positron emission mammography •Others 2.Non ionizing imaging technologies: These can further be sub- segmented as•Breast MRI (Magnetic Resonance Imaging) •Breast Ultrasound •Optical Imaging •Automated whole breast ultrasound (AWBU) •Breast thermography GE Healthcare to hold one of the dominating position in the competitive breast cancer diagnostic market Major players dominating the global breast cancer diagnostic market involves Hologic Inc., GE Healthcare, Phillips Healthcare, Fujifilm Holdings Corporation, Gamma Medica Inc., Toshiba Corporation, Aurora Imaging Technology Inc., and Dilion Technologies Inc. GE Healthcare holds a very strong position in the global breast cancer diagnostic industry due to their high investment costs in R&D that results in introduction of advancement in the field. About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1–206–701–6702 Email: [email protected]
Breast cancer is characterized by a malignant tumor formed in the breast cells, which can spread to other parts of the body. Breast cancer is majorly observed in females. Breast cancer is diagnosed by doctors with the help of several tests to locate the site of initiation and the spread of the tumor to several parts of the body.
© Copyright 2024 Paperzz
